These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36862765)

  • 1. Unsaturated bond recognition leads to biased signal in a fatty acid receptor.
    Mao C; Xiao P; Tao XN; Qin J; He QT; Zhang C; Guo SC; Du YQ; Chen LN; Shen DD; Yang ZS; Zhang HQ; Huang SM; He YH; Cheng J; Zhong YN; Shang P; Chen J; Zhang DL; Wang QL; Liu MX; Li GY; Guo Y; Xu HE; Wang C; Zhang C; Feng S; Yu X; Zhang Y; Sun JP
    Science; 2023 Apr; 380(6640):eadd6220. PubMed ID: 36862765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1β and TNFα inhibit GPR120 (FFAR4) and stimulate GPR84 (EX33) and GPR41 (FFAR3) fatty acid receptor expression in human adipocytes: implications for the anti-inflammatory action of n-3 fatty acids.
    Muredda L; Kępczyńska MA; Zaibi MS; Alomar SY; Trayhurn P
    Arch Physiol Biochem; 2018 May; 124(2):97-108. PubMed ID: 28835131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel GPR120 agonist TUG891 modulates fat taste perception and preference and activates tongue-brain-gut axis in mice.
    Murtaza B; Hichami A; Khan AS; Shimpukade B; Ulven T; Ozdener MH; Khan NA
    J Lipid Res; 2020 Feb; 61(2):133-142. PubMed ID: 31806728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a potent and selective GPR120 agonist.
    Shimpukade B; Hudson BD; Hovgaard CK; Milligan G; Ulven T
    J Med Chem; 2012 May; 55(9):4511-5. PubMed ID: 22519963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR120 agonism as a countermeasure against metabolic diseases.
    Cornall LM; Mathai ML; Hryciw DH; McAinch AJ
    Drug Discov Today; 2014 May; 19(5):670-9. PubMed ID: 24315954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells.
    Mobraten K; Haug TM; Kleiveland CR; Lea T
    Lipids Health Dis; 2013 Jul; 12():101. PubMed ID: 23849180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of GPR120 by TUG891 ameliorated cisplatin-induced acute kidney injury via repressing ER stress and apoptosis.
    Huang Z; Guo F; Xia Z; Liang Y; Lei S; Tan Z; Ma L; Fu P
    Biomed Pharmacother; 2020 Jun; 126():110056. PubMed ID: 32145589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.
    Oh DY; Walenta E; Akiyama TE; Lagakos WS; Lackey D; Pessentheiner AR; Sasik R; Hah N; Chi TJ; Cox JM; Powels MA; Di Salvo J; Sinz C; Watkins SM; Armando AM; Chung H; Evans RM; Quehenberger O; McNelis J; Bogner-Strauss JG; Olefsky JM
    Nat Med; 2014 Aug; 20(8):942-7. PubMed ID: 24997608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of GPR120 agonist-programmed macrophages on renal interstitial fibrosis in unilateral ureteral obstruction (UUO) rats.
    Wang L; Ren X; Tian XF; Cheng XL; Zhao YY; Li QY; Duan ZY; Tian LF; Chen Z; Lu JM; Liang XY; Zhao YF; Fu RG
    Biomed Pharmacother; 2019 Sep; 117():109172. PubMed ID: 31261028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer.
    Liang P; Henning SM; Guan J; Grogan T; Elashoff D; Olefsky JM; Cohen P; Aronson WJ
    J Natl Cancer Inst; 2019 Jan; 111(1):52-59. PubMed ID: 30202902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor.
    Lin DC; Guo Q; Luo J; Zhang J; Nguyen K; Chen M; Tran T; Dransfield PJ; Brown SP; Houze J; Vimolratana M; Jiao XY; Wang Y; Birdsall NJ; Swaminath G
    Mol Pharmacol; 2012 Nov; 82(5):843-59. PubMed ID: 22859723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.
    Oh DY; Talukdar S; Bae EJ; Imamura T; Morinaga H; Fan W; Li P; Lu WJ; Watkins SM; Olefsky JM
    Cell; 2010 Sep; 142(5):687-98. PubMed ID: 20813258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research.
    Li A; Li Y; Du L
    Future Med Chem; 2015; 7(11):1457-68. PubMed ID: 26230883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR120 Inhibits RANKL-Induced Osteoclast Formation and Resorption by Attenuating Reactive Oxygen Species Production in RAW264.7 Murine Macrophages.
    Sithole C; Pieterse C; Howard K; Kasonga A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR120: A bi-potential mediator to modulate the osteogenic and adipogenic differentiation of BMMSCs.
    Gao B; Huang Q; Jie Q; Lu WG; Wang L; Li XJ; Sun Z; Hu YQ; Chen L; Liu BH; Liu J; Yang L; Luo ZJ
    Sci Rep; 2015 Sep; 5():14080. PubMed ID: 26365922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR120 agonists for the treatment of diabetes: a patent review (2014 present).
    Zhang X; Macielag MJ
    Expert Opin Ther Pat; 2020 Oct; 30(10):729-742. PubMed ID: 32799609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonism of GPR120 prevented IL-1β-induced reduction of extracellular matrix through SOX-9.
    Xu Z; Ke T; Zhang Y; Fu C; He W
    Aging (Albany NY); 2020 Jun; 12(12):12074-12085. PubMed ID: 32580167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting FFA1 and FFA4 receptors in cancer-induced cachexia.
    Freitas RDS; Muradás TC; Dagnino APA; Rost FL; Costa KM; Venturin GT; Greggio S; da Costa JC; Campos MM
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E877-E892. PubMed ID: 32893672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation-dependence on GPR120.
    Liang P; Henning SM; Grogan T; Elashoff D; Ye H; Cohen P; Aronson WJ
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):539-546. PubMed ID: 35075215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.
    Takeuchi M; Hirasawa A; Hara T; Kimura I; Hirano T; Suzuki T; Miyata N; Awaji T; Ishiguro M; Tsujimoto G
    Br J Pharmacol; 2013 Apr; 168(7):1570-83. PubMed ID: 22639973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.